Baggiolini M
Theodor Kocher Institute, University of Bern, and Institute for Research in Biomedicine, Bellinzona, Switzerland.
J Intern Med. 2001 Aug;250(2):91-104. doi: 10.1046/j.1365-2796.2001.00867.x.
About 50 human chemokines and nearly 20 receptors have been identified and characterized in little more than a decade since the discovery of interleukin 8 (IL-8), the first chemotactic cytokine. Research in this field has dramatically changed our understanding of leucocyte traffic in inflammation and immunity. This paper has been written for scientists and practitioners in the field of medicine. It reviews in concise and intelligible form information that I consider useful for understanding the role of chemokines in human pathophysiology. The main areas covered are: (i) the basics of chemokine structures, mode of action, activities and selectivity; (ii) newer aspects of the broad involvement of chemokines in the regulation of immune defence and the housekeeping of the immune system; (iii) the role of chemokines in pathology as illustrated by animal models and studies of human diseases; and (iv) novel therapeutic approaches for a variety of inflammatory conditions, which are based on modulation of chemokine activity.
自发现首个趋化细胞因子白细胞介素8(IL-8)以来,在短短十多年间,已鉴定并表征了约50种人类趋化因子和近20种受体。该领域的研究极大地改变了我们对炎症和免疫中白细胞迁移的理解。本文是为医学领域的科学家和从业者撰写的。它以简洁易懂的形式综述了我认为有助于理解趋化因子在人类病理生理学中作用的信息。涵盖的主要领域包括:(i)趋化因子结构、作用方式、活性和选择性的基础知识;(ii)趋化因子广泛参与免疫防御调节和免疫系统日常维护的新方面;(iii)动物模型和人类疾病研究所示趋化因子在病理学中的作用;以及(iv)基于趋化因子活性调节的针对多种炎症性疾病的新型治疗方法。